$TAYD
TAYLOR DEVICES, INC. Stock $tayd

$tayd Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000137647424000456 Filed on August 15, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$11.62M	$12.07M	$44.58M
YoY Change	17.07%	12.55%	10.9%
Cost Of Revenue	$6.114M	$6.174M	$23.74M
YoY Change	10.38%	0.34%	-1.62%
Gross Profit	$5.504M	$5.891M	$20.84M
YoY Change	25.52%	29.0%	29.71%
Gross Profit Margin	47.37%	48.83%	46.74%
Selling, General & Admin	$2.530M	$3.311M	$10.97M
YoY Change	8.29%	45.1%	34.45%
% of Gross Profit	45.96%	56.21%	52.65%
Research & Development	$69.19K	$66.96K	$388.5K
YoY Change	-46.39%	-68.92%	-64.58%
% of Gross Profit	1.26%	1.14%	1.86%
Depreciation & Amortization	$380.2K	$354.4K	$1.690M
YoY Change	-16.53%	-24.37%	14.79%
% of Gross Profit	6.91%	6.02%	8.11%
Operating Expenses	$2.599M	$3.378M	$11.36M
YoY Change	5.42%	35.27%	22.72%
Operating Profit	$2.905M	$2.513M	$9.479M
YoY Change	51.33%	21.44%	39.22%
Interest Expense		$1.427M	$1.427M
YoY Change		104.13%	104.13%
% of Operating Profit		56.77%	15.05%
Other Income/Expense, Net	$376.8K	-$1.108M	$1.441M
YoY Change	4.27%	154.37%	107.0%
Pretax Income	$3.282M	$2.832M	$10.92M
YoY Change	43.88%	21.39%	45.51%
Income Tax	$615.0K	$359.0K	$1.922M
% Of Pretax Income	18.74%	12.68%	17.6%
Net Earnings	$2.667M	$2.473M	$8.999M
YoY Change	44.31%	19.65%	43.12%
Net Earnings / Revenue	22.95%	20.49%	20.18%
Basic Earnings Per Share	$0.85		$2.68
Diluted Earnings Per Share	$0.85	$0.67	$2.58
COMMON SHARES
Basic Shares Outstanding	3.119M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.14M	$30.96M	$30.96M
YoY Change	-11.61%	10.23%	10.23%
Cash & Equivalents	$2.163M	$2.831M	$2.831M
Short-Term Investments	$24.97M	$28.13M	$28.13M
Other Short-Term Assets	$1.618M	$0.00	$725.5K
YoY Change	268.52%	-100.0%	8.52%
Inventory	$8.154M	$7.512M	$11.87M
Prepaid Expenses		$725.5K
Receivables	$6.780M	$5.212M	$5.212M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$48.02M	$48.77M	$48.77M
YoY Change	2.69%	9.9%	9.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.05M	$11.18M	$11.18M
YoY Change	-5.53%	-4.61%	-4.61%
Goodwill
YoY Change
Intangibles		$292.6K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.539M	$27.34K	$2.835M
YoY Change	40.3%	-98.47%	59.08%
Total Long-Term Assets	$13.87M	$14.31M	$14.31M
YoY Change	2.72%	5.96%	5.96%
TOTAL ASSETS
Total Short-Term Assets	$48.02M	$48.77M	$48.77M
Total Long-Term Assets	$13.87M	$14.31M	$14.31M
Total Assets	$61.89M	$63.08M	$63.08M
YoY Change	2.69%	8.98%	8.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.848M	$1.439M	$1.439M
YoY Change	75.75%	-16.23%	-16.23%
Accrued Expenses	$2.396M	$4.664M	$4.379M
YoY Change	-2.7%	14.37%	18.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.971M	$11.83M	$11.83M
YoY Change	-4.28%	51.9%	51.9%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.971M	$11.83M	$11.83M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$7.971M	$11.83M	$11.83M
YoY Change	-4.31%	51.9%	51.9%
SHAREHOLDERS EQUITY
Retained Earnings	$53.79M	$51.13M
YoY Change	22.32%	21.36%
Common Stock	$13.07M	$104.1K
YoY Change	18.13%	1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$12.94M	$12.94M
YoY Change	317.47%	319.61%
Treasury Stock Shares
Shareholders Equity	$53.92M	$51.25M	$51.25M
YoY Change
Total Liabilities & Shareholders Equity	$61.89M	$63.08M	$63.08M
YoY Change	2.69%	8.98%	8.98%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	$2.667M	$2.473M	$8.999M
YoY Change	44.31%	19.65%	43.12%
Depreciation, Depletion And Amortization	$380.2K	$354.4K	$1.690M
YoY Change	-16.53%	-24.37%	14.79%
Cash From Operating Activities	-$3.589M	$6.541M	$13.22M
YoY Change	-218.15%	2.75%	71.52%
INVESTING ACTIVITIES
Capital Expenditures	$247.0K	$394.1K	$1.149M
YoY Change	-42.25%	-59.67%	-65.79%
Acquisitions
YoY Change
Other Investing Activities	$1.113K	-$6.565M	$4.704K
YoY Change	-1.33%	25.29%	-1.2%
Cash From Investing Activities	$2.911M	-$6.959M	-$5.071M
YoY Change	-178.1%	11.94%	-81.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.892M
YoY Change			-6787.52%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$11.01K	192.3K	-$8.892M
YoY Change	282.0%	363.57%	-6787.52%
NET CHANGE
Cash From Operating Activities	-$3.589M	6.541M	$13.22M
Cash From Investing Activities	$2.911M	-6.959M	-$5.071M
Cash From Financing Activities	$11.01K	192.3K	-$8.892M
Net Change In Cash	-$668.0K	-225.0K	-$743.7K
YoY Change	-2.59%	-217.56%	-96.07%
FREE CASH FLOW
Cash From Operating Activities	-$3.589M	$6.541M	$13.22M
Capital Expenditures	$247.0K	$394.1K	$1.149M
Free Cash Flow	-$3.836M	$6.147M	$12.07M
YoY Change	-246.96%	14.07%	177.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	5941304	usd
CY2023Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	4124182	usd
CY2023Q2	us-gaap	Other Inventory Noncurrent OtherInventoryNoncurrent	1003140	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11721784	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	568615	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1218000	usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-05-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-3498
CY2024	dei	Entity Registrant Name EntityRegistrantName	TAYLOR DEVICES INC
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-0797789
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	90 Taylor Drive
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	North Tonawanda
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14120
CY2024	dei	Entity Address Address Description EntityAddressAddressDescription	Address of principal executive offices
CY2024	dei	Phone Fax Number Description PhoneFaxNumberDescription	Registrant's telephone number, including area code
CY2024	dei	City Area Code CityAreaCode	716
CY2024	dei	Local Phone Number LocalPhoneNumber	694-0800
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	81769000	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3118627	shares
CY2024	dei	Auditor Name AuditorName	Lumsden & McCormick, LLP
CY2024	dei	Auditor Firm AuditorFirmId	130
CY2024	dei	Auditor Location AuditorLocation	Buffalo, New York
CY2024	dei	Auditor Name AuditorName	Lumsden & McCormick, LLP
CY2024	dei	Auditor Firm AuditorFirmId	130
CY2024	dei	Auditor Location AuditorLocation	Buffalo, New York
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2831471	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3575219	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	28131279	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	24514757	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5212408	usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5553504	usd
CY2024Q2	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	7512052	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	725506	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	439607	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	0	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	228947	usd
CY2024Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs CostsInExcessOfBillingsOnUncompletedContractsOrPrograms	4356565	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	48769281	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	44377520	usd
CY2024Q2	us-gaap	Other Inventory Noncurrent OtherInventoryNoncurrent	1579829	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11180933	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	292593	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2024Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	214824	usd
CY2023Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	210120	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	27343	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1012615	usd
CY2024Q2	us-gaap	Assets Assets	63077418	usd
CY2023Q2	us-gaap	Assets Assets	57881179	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1438847	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1717657	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4664463	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4078322	usd
CY2024Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	5601274	usd
CY2023Q2	us-gaap	Billings In Excess Of Cost Current BillingsInExcessOfCostCurrent	1992470	usd
CY2024Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	126148	usd
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11830732	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7788449	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.025
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4165315	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4165315	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4088193	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4088193	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	104056	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	102127	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12959531	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10947089	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	51127018	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	42128256	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1046742	shares
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	567751	shares
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	12943919	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	3084742	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	51246686	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	50092730	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63077418	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57881179	usd
CY2024	us-gaap	Revenues Revenues	44582807	usd
CY2023	us-gaap	Revenues Revenues	40199354	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23743554	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23250039	usd
CY2024	us-gaap	Gross Profit GrossProfit	20839253	usd
CY2023	us-gaap	Gross Profit GrossProfit	16949315	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	388476	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1096807	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10971358	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9043442	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	9479419	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	6809066	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	1426584	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	698864	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14759	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2572	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1441343	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	696292	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10920762	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7505358	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1922000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	8998762	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	6287358	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.68
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.79
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.58
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.77
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	51246686	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	50092730	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	8998762	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	6287358	usd
CY2024	us-gaap	Depreciation Depreciation	1690239	usd
CY2023	us-gaap	Depreciation Depreciation	1472455	usd
CY2024	us-gaap	Acquisition Costs AcquisitionCosts	7407	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	0	usd
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1047252	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	417253	usd
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23360	usd
CY2024	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-20015	usd
CY2024	us-gaap	Gain Loss On Condemnation GainLossOnCondemnation	-385744	usd
CY2023	us-gaap	Gain Loss On Condemnation GainLossOnCondemnation	-295014	usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-444000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-494000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-341096	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1110178	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2533181	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	277214	usd
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	285899	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-28882	usd
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-228947	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-7000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-232383	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-787708	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-278810	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	290827	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	586141	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	664008	usd
CY2024	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	3608804	usd
CY2023	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	869707	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	126148	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	27343	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13218924	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7706779	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1149388	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3359495	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	300000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2024	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	3616522	usd
CY2023	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	23417307	usd
CY2024	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4704	usd
CY2023	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4761	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5070614	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26781563	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	967119	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	302705	usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9859177	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	169740	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8892058	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	132965	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-743748	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18941819	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3575219	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22517038	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2831471	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3575219	usd
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font:10pt Times New Roman;margin:0;color:#000080;text-align:justify"><b>Nature of Operations:</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">Taylor Devices, Inc. (the Company) manufactures and sells a single group of very similar products that have many different applications for customers. These similar products are included in one of nine categories; namely, Seismic Dampers, Fluidicshoks®, Crane and Industrial Buffers, Self-Adjusting Shock Absorbers, Liquid Die Springs, Vibration Dampers, Machined Springs, Custom Shock and Vibration Isolators, and Custom Actuators for use in various types of machinery, equipment and structures, primarily to customers which are located throughout the United States and several foreign countries. The products are manufactured at the Company's sole operating facility in the United States where all of the Company's long-lived assets reside. Management does not track or otherwise account for sales broken down by these categories.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">86% of the Company's 2024 revenue was generated from sales to customers in the United States and 4% was from sales to customers in Asia. Remaining sales were to customers in other countries in North America, Europe, Australia, and South America.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">81% of the Company's 2023 revenue was generated from sales to customers in the United States and 11% was from sales to customers in Asia. Remaining sales were to customers in other countries in North America, Europe, Australia, and South America.</p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font:10pt Times New Roman;margin:0;color:#000080;text-align:justify"><b>Use of Estimates:</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1047252	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	417253	usd
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font:10pt Times New Roman;margin:0;color:#000080;text-align:justify"><b>Reclassifications:</b></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify">The 2023 financial statements have been reclassified to conform with the presentation adopted for 2024.</p>
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5241874	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5582970	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	29466	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	29466	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5212408	usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	5553504	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	7571052	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	6009304	usd
CY2024Q2	us-gaap	Inventory Adjustments InventoryAdjustments	59000	usd
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	68000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	7512052	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	5941304	usd
CY2024	fil	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	10576401	usd
CY2023	fil	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	5349111	usd
CY2024	fil	Costs Incurred On Uncompleted Contracts Estimated Earnings CostsIncurredOnUncompletedContractsEstimatedEarnings	10459240	usd
CY2023	fil	Costs Incurred On Uncompleted Contracts Estimated Earnings CostsIncurredOnUncompletedContractsEstimatedEarnings	4850889	usd
CY2024	fil	Costs Incurred On Uncompleted Contracts Gross CostsIncurredOnUncompletedContractsGross	21035641	usd
CY2023	fil	Costs Incurred On Uncompleted Contracts Gross CostsIncurredOnUncompletedContractsGross	10200000	usd
CY2024	fil	Costs Incurred On Uncompleted Contracts Billings To Date CostsIncurredOnUncompletedContractsBillingsToDate	22280350	usd
CY2023	fil	Costs Incurred On Uncompleted Contracts Billings To Date CostsIncurredOnUncompletedContractsBillingsToDate	8068288	usd
CY2024	fil	Costs Incurred On Uncompleted Contracts Net CostsIncurredOnUncompletedContractsNet	-1244709	usd
CY2023	fil	Costs Incurred On Uncompleted Contracts Net CostsIncurredOnUncompletedContractsNet	2131712	usd
CY2024	fil	Costs And Estimated Earnings In Excess Of Billings CostsAndEstimatedEarningsInExcessOfBillings	4356565	usd
CY2023	fil	Costs And Estimated Earnings In Excess Of Billings CostsAndEstimatedEarningsInExcessOfBillings	4124182	usd
CY2024	fil	Billings In Excess Of Costs And Estimated Earnings BillingsInExcessOfCostsAndEstimatedEarnings	-5601274	usd
CY2023	fil	Billings In Excess Of Costs And Estimated Earnings BillingsInExcessOfCostsAndEstimatedEarnings	-1992470	usd
CY2024	fil	Costs Incurred On Uncompleted Contracts Net CostsIncurredOnUncompletedContractsNet	-1244709	usd
CY2023	fil	Costs Incurred On Uncompleted Contracts Net CostsIncurredOnUncompletedContractsNet	2131712	usd
CY2024Q2	fil	Number Of Projects In Progress NumberOfProjectsInProgress	19	pure
CY2023Q2	fil	Number Of Projects In Progress NumberOfProjectsInProgress	22	pure
CY2024Q2	fil	Aggregate Percent Complete AggregatePercentComplete	0.53	pure
CY2023Q2	fil	Aggregate Percent Complete AggregatePercentComplete	0.33	pure
CY2024Q2	fil	Aggregate Amount Remaining AggregateAmountRemaining	17405603	usd
CY2023Q2	fil	Aggregate Amount Remaining AggregateAmountRemaining	18061484	usd
CY2024Q2	fil	Percentage Of Total Value Invoiced To Customer PercentageOfTotalValueInvoicedToCustomer	0.56	pure
CY2023Q2	fil	Percentage Of Total Value Invoiced To Customer PercentageOfTotalValueInvoicedToCustomer	0.29	pure
CY2024	fil	Revenues Recognized For Amounts Included In Billings In Excess Of Costs And Estimated Earnings RevenuesRecognizedForAmountsIncludedInBillingsInExcessOfCostsAndEstimatedEarnings	1992000	usd
CY2023	fil	Revenues Recognized For Amounts Included In Billings In Excess Of Costs And Estimated Earnings RevenuesRecognizedForAmountsIncludedInBillingsInExcessOfCostsAndEstimatedEarnings	1123000	usd
CY2024Q2	fil	Maintenance And Other Inventory Gross MaintenanceAndOtherInventoryGross	2416748	usd
CY2023Q2	fil	Maintenance And Other Inventory Gross MaintenanceAndOtherInventoryGross	2236106	usd
CY2024Q2	fil	Maintenance And Other Inventory Allowance For Obsolescence MaintenanceAndOtherInventoryAllowanceForObsolescence	836919	usd
CY2023Q2	fil	Maintenance And Other Inventory Allowance For Obsolescence MaintenanceAndOtherInventoryAllowanceForObsolescence	1232966	usd
CY2024Q2	fil	Maintenance And Other Inventory Net MaintenanceAndOtherInventoryNet	1579829	usd
CY2023Q2	fil	Maintenance And Other Inventory Net MaintenanceAndOtherInventoryNet	1003140	usd
CY2024	fil	Inventory Disposed Of InventoryDisposedOf	791000	usd
CY2023	fil	Inventory Disposed Of InventoryDisposedOf	322000	usd
CY2024	fil	Provision For Potential Inventory Obsolescence ProvisionForPotentialInventoryObsolescence	386000	usd
CY2023	fil	Provision For Potential Inventory Obsolescence ProvisionForPotentialInventoryObsolescence	295000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30006662	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28857274	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18825729	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17135490	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11180933	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11721784	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1690239	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1472455	usd
CY2024Q2	us-gaap	Other Commitment OtherCommitment	1360000	usd
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	10000000	usd
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2024Q2	fil	Outstanding Checks OutstandingChecks	372347	usd
CY2023Q2	fil	Outstanding Checks OutstandingChecks	13873	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4664463	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4078322	usd
CY2024	us-gaap	Revenues Revenues	44582807	usd
CY2023	us-gaap	Revenues Revenues	40199354	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2365000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1710000	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2000	usd
CY2024	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	2366000	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	1712000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-444000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-494000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-444000	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-494000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1922000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1218000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2293400	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1576100	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1600	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	407675	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	283600	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	142100	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	66900	usd
CY2024	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	48500	usd
CY2023	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	0	usd
CY2024	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	2800	usd
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	900	usd
CY2024	fil	Other Adjustments OtherAdjustments	127075	usd
CY2023	fil	Other Adjustments OtherAdjustments	-6900	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1922000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1218000	usd
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.176	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.162	pure
CY2024Q2	fil	Allowance For Doubtful Receivables AllowanceForDoubtfulReceivables	6200	usd
CY2023Q2	fil	Allowance For Doubtful Receivables AllowanceForDoubtfulReceivables	6200	usd
CY2024Q2	fil	Tax Inventory Adjustment TaxInventoryAdjustment	57300	usd
CY2023Q2	fil	Tax Inventory Adjustment TaxInventoryAdjustment	84300	usd
CY2024Q2	fil	Allowance For Obsolete Inventory AllowanceForObsoleteInventory	188100	usd
CY2023Q2	fil	Allowance For Obsolete Inventory AllowanceForObsoleteInventory	273200	usd
CY2024Q2	fil	Accrued Vacation AccruedVacation	163000	usd
CY2023Q2	fil	Accrued Vacation AccruedVacation	136600	usd
CY2024Q2	fil	Accrued Commissions AccruedCommissions	0	usd
CY2023Q2	fil	Accrued Commissions AccruedCommissions	9800	usd
CY2024Q2	fil	Warranty Reserve WarrantyReserve	100700	usd
CY2023Q2	fil	Warranty Reserve WarrantyReserve	62700	usd
CY2024Q2	fil	Rd Tax Credit RDTaxCredit	0	usd
CY2023Q2	fil	Rd Tax Credit RDTaxCredit	0	usd
CY2024Q2	fil	Rd Capitalization RDCapitalization	1479800	usd
CY2023Q2	fil	Rd Capitalization RDCapitalization	678500	usd
CY2024Q2	fil	Stock Options Issued For Services StockOptionsIssuedForServices	181200	usd
CY2023Q2	fil	Stock Options Issued For Services StockOptionsIssuedForServices	331300	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2176300	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1582600	usd
CY2024Q2	fil	Excess Tax Depreciation ExcessTaxDepreciation	1163685	usd
CY2023Q2	fil	Excess Tax Depreciation ExcessTaxDepreciation	1013985	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1012615	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	568615	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2176300	usd
CY2024	fil	Average Common Shares Outstanding AverageCommonSharesOutstanding	3353077	shares
CY2023	fil	Average Common Shares Outstanding AverageCommonSharesOutstanding	3506474	shares
CY2024	fil	Common Shares Issuable Under Stock Option Plans CommonSharesIssuableUnderStockOptionPlans	135711	shares
CY2023	fil	Common Shares Issuable Under Stock Option Plans CommonSharesIssuableUnderStockOptionPlans	45020	shares
CY2024	fil	Average Common Shares Outstanding Assuming Dilution AverageCommonSharesOutstandingAssumingDilution	3488788	shares
CY2023	fil	Average Common Shares Outstanding Assuming Dilution AverageCommonSharesOutstandingAssumingDilution	3551494	shares
CY2024	fil	Common Shares Issued To Employees CommonSharesIssuedToEmployees	372	shares
CY2023	fil	Common Shares Issued To Employees CommonSharesIssuedToEmployees	922	shares
CY2024Q2	fil	Shares Reserved For Further Issue SharesReservedForFurtherIssue	215993	shares
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0245	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M18D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y2M12D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.37	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.33	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	283000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.43
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28248	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	85000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.75
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	30500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.57
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	4500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	333000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.7
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2016961	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	85000	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	34.04
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	76750	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.54
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	750	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	340500	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.07
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11185815	usd
CY2024	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	431720	usd
CY2023	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	371881	usd
CY2024	us-gaap	Interest Paid InterestPaid	0	usd
CY2023	us-gaap	Interest Paid InterestPaid	0	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2010000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1705000	usd
CY2024	us-gaap	Loss Contingency Parties Jointly And Severally Liable In Litigation LossContingencyPartiesJointlyAndSeverallyLiableInLitigation	The Company has been named as a third-party defendant
CY2024	us-gaap	Loss Contingency Name Of Plaintiff LossContingencyNameOfPlaintiff	Board of Managers of the 432 Park Condominium, et al.
CY2024	us-gaap	Loss Contingency Lawsuit Filing Date1 LossContingencyLawsuitFilingDate1	2021-09-23
CY2024	us-gaap	Loss Contingency Allegations LossContingencyAllegations	design defects to the residential and commercial units at the Building

Files In Submission

Name	View Source	Status
0001376474-24-000456-index-headers.html	Edgar Link	pending
0001376474-24-000456-index.html	Edgar Link	pending
0001376474-24-000456.txt	Edgar Link	pending
0001376474-24-000456-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tayd-20240531.htm	Edgar Link	pending
tayd-20240531.xsd	Edgar Link	pending
td_ex10z10-0001.jpg	Edgar Link	pending
td_ex10z10-0002.jpg	Edgar Link	pending
td_ex10z10-0003.jpg	Edgar Link	pending
td_ex10z10-0004.jpg	Edgar Link	pending
td_ex10z10-0005.jpg	Edgar Link	pending
td_ex10z10-0006.jpg	Edgar Link	pending
td_ex10z10.htm	Edgar Link	pending
td_ex10z11-0001.jpg	Edgar Link	pending
td_ex10z11-0002.jpg	Edgar Link	pending
tayd-20240531_def.xml	Edgar Link	unprocessable
tayd-20240531_lab.xml	Edgar Link	unprocessable
tayd-20240531_htm.xml	Edgar Link	completed
td_ex10z11-0003.jpg	Edgar Link	pending
td_ex10z11-0004.jpg	Edgar Link	pending
td_ex10z11-0005.jpg	Edgar Link	pending
td_ex10z11-0006.jpg	Edgar Link	pending
td_ex10z11-0007.jpg	Edgar Link	pending
td_ex10z11-0008.jpg	Edgar Link	pending
td_ex10z11.htm	Edgar Link	pending
td_ex31z1.htm	Edgar Link	pending
td_ex31z2.htm	Edgar Link	pending
td_ex32z1.htm	Edgar Link	pending
td_ex32z2.htm	Edgar Link	pending
td_ex3z1.htm	Edgar Link	pending
td_ex97.htm	Edgar Link	pending
tayd-20240531_cal.xml	Edgar Link	unprocessable
tayd-20240531_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TAYD
TAYLOR DEVICES, INC. Stock $tayd

2024 Q3 Form 10-K Financial Statement

#000137647424000456 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TAYD TAYLOR DEVICES, INC. Stock $tayd

2024 Q3 Form 10-K Financial Statement

#000137647424000456 Filed on August 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TAYD
TAYLOR DEVICES, INC. Stock $tayd